- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03464617
Doppler Flow Classification of Saint-Bonnet (Saint-Bonnet)
March 15, 2018 updated by: Rennes University Hospital
Doppler Flow Classification of Saint-Bonnet : A Non Interventional Clinical Trial
Observational Study that evaluates the interest of Doppler waveforms classification in Peripheral Artery disease
Study Overview
Status
Unknown
Conditions
Detailed Description
Patients who have Doppler ultrasound scanning in clinical practice currently have a systematic record of Doppler flow on arterial axes of the aorta and right and left lower limbs.
The investigators will analyze a posteriori Doppler flow of patients by classifying them using the 3 classifications.
The patient will have no constraints related to this study since the recordings are currently performed in clinical routine.
Study Type
Observational
Enrollment (Anticipated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amiens, France, 80000
- Recruiting
- CHU AMIENS
-
Contact:
- SEVESTRE
-
Bordeaux, France
- Recruiting
- CHU de Bordeaux
-
Contact:
- CONSTANS
-
Brest, France, 29000
- Recruiting
- CHU Brest
-
Contact:
- LUC BRESSOLLETTE, MD PhD
- Email: luc.bressollette@chu-brest.fr
-
Caen, France, 14000
- Recruiting
- CHU De Caen
-
Contact:
- LANEELLE
-
Grenoble, France, 38000
- Recruiting
- CHU de Grenoble
-
Contact:
- PERNOD
-
Limoges, France, 87100
- Recruiting
- CHU de Limoges
-
Contact:
- LACROIX
-
Rennes, France, 35033
- Recruiting
- CHU de RENNES
-
Contact:
- MAHE GUILLAUME
- Phone Number: 02.99.28.75.29
- Email: guillaume.mahe@chu-rennes.fr
-
Saint-Étienne, France, 42100
- Recruiting
- Chu de Saint-Etienne
-
Contact:
- HELLO CLAIRE
-
Toulouse, France, 31555
- Recruiting
- CHU de Toulouse
-
Contact:
- BURA-RIVIERE
-
Vichy, France, 03200
- Recruiting
- CH de Vichy
-
Contact:
- ABBADIE FABRICE
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients addressed in a vascular center for vascular ultrasound
Description
Inclusion Criteria:
- Age greater than or equal to 18 years;
- Social insured
- Patients referred in the department for any arterial examination of the lower limbs.
Exclusion Criteria:
- Patient unfit to understand the instructions of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Doppler flows
Time Frame: Baseline
|
The difference between the number of unclassified Doppler flows using the Saint-Bonnet classification and the number of unclassified flows using the Spronk et al.
This comparison will be done using the Mc Nemar test.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2016
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
March 7, 2018
First Submitted That Met QC Criteria
March 7, 2018
First Posted (Actual)
March 14, 2018
Study Record Updates
Last Update Posted (Actual)
March 19, 2018
Last Update Submitted That Met QC Criteria
March 15, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35RC18_3099_SaintBonnet
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Marissa JarosinskiTerminatedPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Wroclaw Medical UniversityPoznan University of Medical Sciences; Military Institute of Medicine National...RecruitingPeripheral Arterial Disease(PAD)Poland
-
Louisiana State University Health Sciences Center...Not yet recruitingPeripheral Arterial Disease(PAD)United States
-
BayerCompleted
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany